Fecal microbiota changes with the consumption of follow-up formulas containing Bifidobacterium spp. and/or galactooligosaccharides by rats and a follow-up infant formula containing Bifidobacterium spp. by human infants

D. Perez-Conesa, G. Lopez, G.H. Ros, P. Abellan, R. Hartemink

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Scopus)

Abstract

Seven groups of rats were fed during 1 mo using 1 infant formula containing Bifidobacterium bifidum and Bifidobacterium longum, 3 infant formulas containing 4-galactosyllactose at 1.2%, 5.0%, and 10.0%, and 3 infant formulas containing both ingredients. During 3 periods, corresponding to day 8 to 10, 18 to 20, and 28 to 30, fecal samples were collected for total aerobes, total anaerobes, and bifidobacteria counts. Results showed that bifidobacteria represented an important proportion out of the anaerobe group in the 1st period. However, in the 2nd period bifidobacteria decreased significantly, and in the 3rd period bifidobacteria counts increased, especially in the group fed diet containing galactooligosaccharides 1.2%. In a 2nd study, 12 human infants were fed with the infant formula containing B. bifidum and B. longum, whereas the other 12 were fed using a control infant formula. Fecal samples were collected at the age of 1, 3, 5, 7, 9, and 12 mo for total anaerobes, bacteroides, bifidobacteria, clostridia counts, as well as for fecal pH determination. Infants fed infant formula containing bifidobacteria in samples corresponding to 7th and 9th mo of age had significantly (P<0.05) higher bifidobacteria counts and a lower fecal pH than those fed control infant formula
Original languageEnglish
Pages (from-to)M7-M13
JournalJournal of Food Science
Volume71
Issue number1
DOIs
Publication statusPublished - 2006

Keywords

  • bottle-fed infants
  • intestinal microflora
  • selective medium
  • human-milk
  • flora
  • probiotics
  • prebiotics
  • newborn
  • agar

Fingerprint Dive into the research topics of 'Fecal microbiota changes with the consumption of follow-up formulas containing Bifidobacterium spp. and/or galactooligosaccharides by rats and a follow-up infant formula containing Bifidobacterium spp. by human infants'. Together they form a unique fingerprint.

  • Cite this